Rajiv Panwar

Dr Panwar is our Vice President and Head of Chemistry, Manufacturing, and Controls (CMC).

He brings more than a decade of experience in CMC leadership across all areas, including process, analytical, formulation, and manufacturing, for biologics and other therapeutic modalities. He most recently served as VP, CMC and Clinical Supply Chain, at Disc Medicine, where he advanced multiple small molecule and monoclonal antibody programs into development, including initiating late-stage CMC activities in support of NDA filing readiness. Prior to Disc, Dr Panwar held roles of increasing responsibility at Magenta Therapeutics, where he served as Head of Technical Operations, supporting GMP manufacturing campaigns for a variety of therapeutic modalities, including antibodies and antibody-drug conjugates. Before Magenta, he was Head of Analytical CMC at Eleven Biotherapeutics (later Sesen Bio), where he led CMC activities in support of Phase 2/3 clinical trials for multiple biologics.

Dr Panwar holds an MS/PhD in Interdisciplinary Pharmaceutical Sciences from Northeastern University and a BS in Pharmaceutical Sciences from MD University in India.